首页> 外文期刊>Vaccine >Differences in the priming effect of various clades/subclades of inactivated H5N1 vaccine for booster injection with heterologous clades of vaccine strains
【24h】

Differences in the priming effect of various clades/subclades of inactivated H5N1 vaccine for booster injection with heterologous clades of vaccine strains

机译:灭活H5N1疫苗的各个进化枝/亚进化枝与疫苗株的异源进化枝进行加强注射时的引发效果差异

获取原文
获取原文并翻译 | 示例
           

摘要

The prime-boost response induced by different combinations of four H5N1 vaccines (NIBRG-14 (clade 1), Indo05/2005(H5N1)/PR8-IBCDC-RG2 (clade 2.1), A/Bar-Headed Goose/Qinhai Lake/1A/05 SJ163222 (clade 2.2), and Anhui01/2005(H5N1)-PR8-IBCDC-RG5 (clade 2.3.4)) was evaluated in mice. Clade 1-primed BALB/c mice showed a booster response to all of the other three H5N1 vaccines. Cade 2.2 vaccine was also a good priming vaccine. However, mice primed with clade 2.1 or clade 2.3.4 vaccine did not respond to booster injection with clade 1 vaccine, suggesting that priming might actually inhibit the booster response with some combinations of vaccines belonging to different clades. Analysis of the mechanism involved showed that lymphocytes from primed mice secreted comparable amounts of cytokines with any combination of priming and booster vaccines. Therefore, impairment of B cell immunity specific to certain booster strains may have been involved
机译:四种H5N1疫苗(NIBRG-14(clade 1),Indo05 / 2005(H5N1)/ PR8-IBCDC-RG2(clade 2.1),A / Bar-Headed Goose / Qinhai Lake / 1A)的不同组合诱导的初免-加强反应在小鼠中评估了/ 05 SJ163222(clade 2.2)和Anhui01 / 2005(H5N1)-PR8-IBCDC-RG5(clade 2.3.4))。 Clade 1引发的BALB / c小鼠显示出对所有其他三种H5N1疫苗的加强应答。 Cade 2.2疫苗也是很好的初免疫苗。但是,使用第2.1进化枝或第2.3.4进化枝疫苗引发的小鼠对第1进化枝疫苗的加强注射无反应,这表明,使用属于不同进化枝的某些疫苗组合,引发实际上可能抑制了加强免疫。对涉及机制的分析表明,初免和加强免疫疫苗的任何组合均可使初免小鼠的淋巴细胞分泌相当数量的细胞因子。因此,可能涉及特定加强型菌株的B细胞免疫力受损

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号